To test if the PD-L1 tumor-intrinsic pathway can be activated by its binding partner, we treated MDA-MB-231 cells with purified recombinant PD-1 extracellular domain, then determined p38-MAPK activity. This evidence concerns the gene CD274 and neoplasm.